Tycel Phillips, MD, City of Hope, Duarte, CA, shares some updates from the EPCORE NHL-1 trial (NCT03625037), which is evaluating the safety and efficacy of subcutaneous epcoritamab in patients with relapsed/refractory (R/R) large B-cell lymphoma (LBCL). This interview took place at the Tenth Annual Meeting of the Society of Hematologic Oncology (SOHO) held in Houston, TX.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.